Treatment
Medication clinical trials
We’re tracking 7,139 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06413992RecruitingPhase 2
Camrelizumab plus fluzoparib for TP53-mutated endometrial cancer
This trial tests a combination of two drugs, camrelizumab (an immunotherapy) and fluzoparib (a PARP inhibitor), for people with a specific type of endometrial cancer that has a TP53 gene mutation. It may offer a new option for advanced or recurrent disease after limited prior treatment.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05421143Recruiting
Test a personal plan to help people take medicines safely after discharge
This study is designing and testing a person-centered plan to help you use your medicines correctly when you leave the hospital. It involves you, your family or caregiver, and your usual healthcare team to reduce medication problems across care settings.
OsloAges 18 years+ - NCT05479669Recruiting
Testing detailed heart scans in people with heart failure symptoms
This study looks at whether doing very detailed heart testing helps understand and guide care for people with heart failure with preserved pumping strength. You may be eligible if you’re an adult with specific symptom levels, recent heart-failure-related visits, and matching scan and blood test results.
GroningenAges 18 years+ - NCT06410833RecruitingPhase 4
Combination therapy for resistant Sjögren's in children
This trial tests a combination of two medicines, rituximab then belimumab, for children and teens with Sjögren's syndrome that hasn't improved with other treatments. The goal is to see if this two-step approach can better control symptoms like joint pain, skin rashes, and blood problems.
Beijing, Beijing MunicipalityAges 5–18 - NCT06417567Recruiting
Preventing nausea and vomiting after GI cancer surgery
This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT06261554Recruiting
Low-dose sesame oral immunotherapy for children
This study tests if a very low daily dose of sesame protein (given as a powder under the tongue) can help children with sesame allergy become less sensitive to sesame. The goal is to reduce the risk of severe allergic reactions from accidental exposure.
Warsaw, Masovian VoivodeshipAges 3–17 - NCT06417502Recruiting
China pediatric rheumatic disease registry study
This study collects information from children with rheumatic and immune system diseases in China to better understand these conditions. By participating, you help researchers learn more about how to diagnose and treat these diseases.
Beijing, Beijing MunicipalityAges Up to 18 years - NCT06418165Recruiting
Cooled oxygenated machine perfusion for liver transplant
This study tests a new way to preserve donated livers using a machine that keeps the organ cool and oxygenated before transplant. It may help improve how well the liver works after the surgery.
ViennaAges 18 years+ - NCT06421805Recruiting
Mediastinal Tumor Patient Database Study
This study is building a database of people with mediastinal tumors. It will collect health information over time to help doctors better understand these tumors and improve care.
Beijing, Beijing MunicipalityAges Any age - NCT05680246Recruiting
Study of long-term outcomes after special donor-liver preservation
This study looks at how well people do in the long run after liver transplant using donor livers that were preserved in a specific machine called DHOPE for more than 4 hours. It may help doctors understand whether this preservation method leads to better transplant outcomes over time.
GroningenAges 18 years+ - NCT06423014Recruiting
Smartphone program for boosting physical activity
This trial tests a smartphone-based program to help inactive adults become more physically active. It uses your phone's features and simple activity trackers to encourage daily movement and better health.
TaipeiAges 18–70 - NCT07850843Enrolling by invitationPhase 2
Apremilast with antihistamines for chronic hives
This trial tests whether adding apremilast, a medicine that reduces inflammation, helps people with chronic hives when antihistamines alone aren't enough. It may offer a new option for those who can't use other standard treatments like omalizumab or cyclosporine.
Lahore, Punjab ProvinceAges 18–65 - NCT07852091RecruitingPhase 2
Combination therapy aiming for a functional cure for chronic hepatitis B
This study tests a new combination of medicines to help your immune system control the hepatitis B virus, with the goal of stopping the need for long-term treatment. It may be an option for people who have taken or are currently taking hepatitis B medications.
Chongqing, Chongqing MunicipalityAges 18–60 - NCT07852806Recruiting
Bone marrow cells for repairing severe jaw bone defects
This trial tests whether using your own bone marrow cells can help repair severe bone loss in the jaw. It may offer a new way to rebuild bone for people who need a bone graft.
Nanjing, JiangsuAges 16–60 - NCT07851779RecruitingPhase 4
Stopping heart failure drugs after excellent response to cardiac resynchronization therapy
This trial studies whether patients with non-ischemic cardiomyopathy who have responded extremely well to a special pacemaker (CRT) can safely stop their heart failure medications. It aims to see if their heart function stays stable without these drugs.
L'Hospitalet de Llobregat, BarcelonaAges 18 years+ - NCT07852624Recruiting
Anesthesia during planned c-section and newborn hearing
This study compares two types of anesthesia used during planned cesarean deliveries to see if they affect the baby's hearing after birth. If you qualify, you would receive one of the standard anesthesia methods, and your baby's hearing would be checked shortly after delivery.
WenzhouAges 18–35 - NCT07853014Recruiting
Virtual reality to ease anxiety during wisdom tooth surgery
This study tests whether using virtual reality (a headset showing calming images) helps reduce anxiety during lower wisdom tooth surgery. If you're having this procedure, the virtual reality might make the experience less stressful.
Hanoi, HanoiAges 18 years+ - NCT06421818RecruitingPhase 2
Baitouweng Decoction for ulcerative colitis with damp-heat
This trial tests a traditional Chinese herbal formula called Baitouweng Decoction for people with mild to moderate ulcerative colitis who also have a specific pattern of symptoms called 'damp-heat' in the large intestine. It aims to see if the medicine can help reduce inflammation and improve symptoms.
Nanjing, JiangsuAges Any age - NCT06425848Recruiting
Heart failure monitoring study
This study looks at how a small monitor inside the blood vessel to the lungs helps manage heart failure. It aims to improve care for people with advanced heart failure.
La Jolla, CaliforniaAges 18–100 - NCT06425224RecruitingPhase 3
TENS therapy for premature ejaculation
This trial tests if a painless electrical nerve stimulation (TENS) treatment can help men with premature ejaculation last longer and feel more in control. It's for men who have had this condition for at least 6 months and are in a stable relationship.
Mexico CityAges 18–62 - NCT06426810Recruiting
New vs. standard surgical tool for bleeding control after lymph node biopsy
This trial compares two tools used during surgery to stop bleeding after a sentinel lymph node biopsy for breast cancer. It aims to see if a newer bipolar system is better than the standard electrocautery device.
Seoul, Dongjak-guAges 20–80 - NCT05725512RecruitingPhase 4
Prednisolone to prevent unexplained recurrent miscarriages
This trial tests whether a medicine called prednisolone can help prevent further miscarriages in people who have had recurrent miscarriages with no known cause. If you qualify, you would take prednisolone early in pregnancy and the study team would watch whether more losses occur.
Leiden, South HollandAges 18–40 - NCT06429839RecruitingPhase 2
Nimotuzumab with chemoradiation for esophageal cancer
This trial tests a drug called nimotuzumab combined with standard chemotherapy and radiation for patients with esophageal cancer. It may help improve treatment effectiveness for those whose cancer has not spread to other parts of the body.
BeijingAges 18–80 - NCT06430762Recruiting
Study of risk factors for jaw bone damage from certain drugs
This study looks at people who have jaw bone damage (osteonecrosis) caused by medications. Researchers want to understand what treatments and risk factors are linked to this condition to help improve care.
IstanbulAges 18–110
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,139 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.